Key facts
- This page summarizes Elder Granger's Form 4 filing for Better Therapeutics, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 07 Dec 2021, 15:23.
Elder Granger - 03 Dec 2021 Form 4 Insider Report for Better Therapeutics, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 03 Dec 2021
- Net transaction value
- +$6,660
- SEC form
- 4
- Accepted by SEC
- 07 Dec 2021, 15:23:45 UTC
- Prior SEC filing
- 02 Dec 2021
- Next SEC filing
- 02 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mark Heinen, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Elder Granger filed Form 4 for Better Therapeutics, Inc. on 07 Dec 2021.
Change
- Previous filing in this sequence was filed on 02 Dec 2021.
- Current net transaction value: +$6,660.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BTTX
transaction
Common Stock
Purchase
- Transaction value
- $6,660
- Shares
- +1,000
- Change %
- Price
- $6.66*
- Shares after
- 1,000
- Date
- 03 Dec 2021
- Ownership
- Direct
* marks a reported price that did not pass the local price check.